Skip to main content
Clinical Trials/ACTRN12624000786594
ACTRN12624000786594
Not yet recruiting
未知

Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – the ERADICATE study: a phase II randomised controlled trial

Edith Cowan University0 sites50 target enrollmentJune 26, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Edith Cowan University
Enrollment
50
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • I) Patients diagnosed with localised or locally advanced prostate cancer;
  • II) Patients scheduled for conventional or moderately hypofractionated external beam radiotherapy; and
  • III) Approval from treating oncologist to participate in study.

Exclusion Criteria

  • I) Previous radical prostatectomy;
  • II) Patients already engaging in regular exercise (defined as undertaking structured, i.e. planned and individualised, aerobic or resistance exercise on 2 or more days per week within the past 3 months);
  • III) Acute illness or musculoskeletal/ cardiovascular/ neurological disorder that could put patients at risk during exercise testing or training;
  • IV) Bone metastases; and
  • V) Contraindication to magnetic resonance imaging.

Outcomes

Primary Outcomes

Not specified

Similar Trials